These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 11358811

  • 21. Gender differences in p53 mutational status in small cell lung cancer.
    Tseng JE, Rodriguez M, Ro J, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Nov 15; 59(22):5666-70. PubMed ID: 10582680
    [Abstract] [Full Text] [Related]

  • 22. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL, Yoshizato K, Kluwe L, Meissner H, Warnecke G, Zapf S, Westphal M, Deppert W, Giese A.
    Anticancer Res; 2005 Nov 15; 25(1A):213-24. PubMed ID: 15816541
    [Abstract] [Full Text] [Related]

  • 23. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.
    Lung Cancer; 2006 Apr 15; 52(1):9-14. PubMed ID: 16499995
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J.
    Cancer Res; 2009 Apr 15; 69(8):3625-33. PubMed ID: 19336573
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J.
    Acta Oncol; 2008 Apr 15; 47(4):600-7. PubMed ID: 18465328
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4067-73. PubMed ID: 15930341
    [Abstract] [Full Text] [Related]

  • 33. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
    Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Crinière E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY.
    Cancer Genet Cytogenet; 2007 Sep 01; 177(2):103-7. PubMed ID: 17854663
    [Abstract] [Full Text] [Related]

  • 34. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL, Dean RC, Zhang W, Young D, Sesterhenn IA, Shanmugam N, McLeod DG, Moul JW, Srivastava S.
    Prostate Cancer Prostatic Dis; 2003 Sep 01; 6(4):281-5. PubMed ID: 14663467
    [Abstract] [Full Text] [Related]

  • 35. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T.
    Nat Genet; 2000 Sep 01; 26(1):109-13. PubMed ID: 10973261
    [Abstract] [Full Text] [Related]

  • 36. Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.
    Chen YJ, Hakin-Smith V, Teo M, Xinarianos GE, Jellinek DA, Carroll T, McDowell D, MacFarlane MR, Boet R, Baguley BC, Braithwaite AW, Reddel RR, Royds JA.
    Cancer Res; 2006 Jul 01; 66(13):6473-6. PubMed ID: 16818615
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M, Bishehsari F, Verginelli F, Cumashi A, Lattanzio R, Sotoudeh M, Ansari R, Semeraro D, Hormazdi M, Fakheri H, Rakhshani N, De Lellis L, Curia MC, Cama A, Piantelli M, Malekzadeh R, Iacobelli S, Mariani-Costantini R.
    J Cell Physiol; 2008 Aug 01; 216(2):543-50. PubMed ID: 18330889
    [Abstract] [Full Text] [Related]

  • 39. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Amato A, Calò V, Dardanoni G, Morello V, La Farina M, Albanese I, Tomasino RM, Gebbia N, Russo A.
    J Cell Physiol; 2002 May 01; 191(2):237-46. PubMed ID: 12064467
    [Abstract] [Full Text] [Related]

  • 40. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R, Hussain I, Afroze D, Aejazaziz S, Jan M, Shah ZA, Das BC, Siddiqi MA.
    Cancer Lett; 2007 Apr 18; 248(2):308-20. PubMed ID: 16996204
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.